Contraception in women with special medical needs
- PMID: 9626481
Contraception in women with special medical needs
Abstract
Over 10% of women of reproductive age have experienced a serious chronic physical disorder. Reproductive health issues including contraception are frequently ignored in these individuals. Clinicians should have available current knowledge regarding interactions between contraception and these conditions.
PIP: Over 10% of US women have experienced a serious chronic physical disorder or disease by the age of 18 years. Nonetheless, health professionals frequently are unprepared to counsel women with special medical problems about sexuality issues, including the potential adverse effects of pregnancy and contraception on underlying disease. This article, based on a comprehensive review of the clinical literature, summarizes significant contraception-related considerations in women with specific medical conditions. Special emphasis is awarded to cardiovascular and neurologic diseases. In women with cardiac disease, both the cardiovascular sequelae of pregnancy should the contraceptive fail and the potential adverse circulatory effects of various contraceptive methods must be considered. In women with neurologic disease, a method must be selected that will not interact with anticonvulsants or immunosuppressive medications. Also reviewed are indicated and contraindicated contraceptive methods for women with pulmonary, gastrointestinal, endocrine, hematologic, renal, and rheumatologic disease; HIV/AIDS; cancer; and psychiatric morbidity. Tables review World Health Organization medical eligibility criteria for use of the major contraceptive methods, medications that potentially reduce or enhance the efficacy of oral contraceptives (OCs), and drugs whose efficacy may be affected by concomitant OC use.
Similar articles
-
Contraception in women with intercurrent disease.Curr Opin Obstet Gynecol. 1994 Dec;6(6):547-51. Curr Opin Obstet Gynecol. 1994. PMID: 7893962 Review.
-
Oral contraceptives: Pt. 2.Fam Plann Inf Serv. 1978 Apr-May;1(2):1-36. Fam Plann Inf Serv. 1978. PMID: 12338652
-
Psychiatrically impaired patients often exposed to pregnancy risk.Contracept Technol Update. 1985 Jun;6(6):88-90. Contracept Technol Update. 1985. PMID: 12313658
-
Weighing risks against benefits in contraceptive safety.Draper Fund Rep. 1983 Aug;(12):20-2. Draper Fund Rep. 1983. PMID: 12338977
-
Depo Provera. Position paper on clinical use, effectiveness and side effects.Br J Fam Plann. 1999 Jul;25(2):69-76. Br J Fam Plann. 1999. PMID: 10454658 Review.
Cited by
-
Pharmacokinetic drug interactions between oral contraceptives and second-generation anticonvulsants.Clin Pharmacokinet. 2000 Apr;38(4):355-65. doi: 10.2165/00003088-200038040-00004. Clin Pharmacokinet. 2000. PMID: 10803456 Review.
-
The treatment of adolescents with a chronic illness: physicians must go beyond the medical model.West J Med. 2001 Nov;175(5):293-5. doi: 10.1136/ewjm.175.5.293. West J Med. 2001. PMID: 11694463 Free PMC article. No abstract available.
-
Sexual and reproductive health in young people with congenital heart disease: a systematic review of the literature.Pediatr Cardiol. 2005 Nov-Dec;26(6):805-11. doi: 10.1007/s00246-005-0950-3. Pediatr Cardiol. 2005. PMID: 16078118
-
Therapeutic amenorrhea in patients at risk for thrombocytopenia.Obstet Gynecol Surv. 2008 Jun;63(6):395-402; quiz 405. doi: 10.1097/OGX.0b013e3181706620. Obstet Gynecol Surv. 2008. PMID: 18492296 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical